Double-Blinding and Bias in Medication and Cognitive-Behavioral Therapy Trials for Major Depressive Disorder, 2015, Berger

Full reference: Berger, D. (2015). Double-blinding and bias in medication and cognitive-behavioral therapy trials for major depressive disorder. F1000Research, 4.

Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732552/

Abstract:

 

1. If there isn't good evidence it generally shouldn't be offered under the umbrella of mainstream medicine
2. If studies are not designed to produce reliable evidence they shouldn't be approved or funded
3. See 1.

 

Already discussed here: https://www.s4me.info/threads/bias-due-to-a-lack-of-blinding-a-discussion.11429/#post-203661

Unfortunately, Berger is not uncontroversial.

 

Thanks, @Michiel Tack! I just independently re-read your previous thread and came here now to link to it myself!

 

My personal preferred term is "randomised comparison trial", rather than "randomised controlled trial"...